about
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing A...
Read More
1.43
-0.04
(-2.72%)
259.2K
XNAS Volume
XNAS 26 Aug, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for iBio Inc is on 04 Sep 2026 for the purpose of iBio Inc Fourth Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Neutral
iBio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..